Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
about
Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrixGenomic Contributors to Rhythm Outcome of Atrial Fibrillation Catheter Ablation - Pathway Enrichment Analysis of GWAS DataPresence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway.Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes.Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation.Age and sex differences in atrial fibrosis among patients with atrial fibrillation.Stroke risk in patients with device-detected atrial high-rate episodes.The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey.Association of left atrial low-voltage area and thromboembolic risk in patients with atrial fibrillation.Incidence of left atrial thrombus prior to catheter ablation of atrial fibrillation: Is it time for atrial cardiomyopathy evaluation?Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction.Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients.Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.Risk Factor Management in Atrial Fibrillation.
P2860
Q28066160-870E7417-BE44-4501-BC45-DD9FEDF39139Q30000298-9282A979-4501-4C6F-9A1E-8DC37B174D78Q36306317-D7549F52-427F-436F-A569-9E0C8AA2AD30Q36320921-767FDFD0-0CC5-453D-852A-5C5599AB241CQ40127983-740218B8-BDD9-411C-ADDF-63CFC78AD515Q40275970-86A4721D-5EB9-4118-BF66-60CD1AB02762Q47106384-EA7509D1-0B28-4773-8B68-E58B21FB32A7Q47247465-2B1FE931-ADBA-45EF-9431-28767554F07DQ47422045-027A0E3D-890C-436E-A0E6-C1EE842C5629Q47744006-9B207286-DA06-40CF-9AEA-2DDD8679266CQ47827710-C62E1BBA-7217-4C67-8871-7F95AF41F741Q48126562-DA4EFD85-D667-4B2D-AE71-796785B9EB5AQ48522025-B8DC4A95-4E74-4AD0-BE59-E79059F1C114Q49850138-E990AF7C-14D5-4AFF-A041-73F442F3C26CQ49874468-55529FEC-C199-4A44-8A91-47FBD61D6D1BQ50047552-88EBE1F4-47DF-497D-BD75-EE68FC80F1CCQ52345203-35756056-2C06-45A5-A8E2-E698AF217327Q55411533-7C329019-E4D9-42D1-B418-676424F0F3D9
P2860
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@en
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@nl
type
label
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@en
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@nl
prefLabel
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@en
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@nl
P2093
P2860
P50
P356
P1476
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
@en
P2093
Alexander H Maass
Anne Margreet De Jong
Arne van Hunnik
Harry J Crijns
Henri M H Spronk
Hetty C De Boer
Hugo Ten Cate
Marion Kuiper
Pieter Willem Kamphuisen
Sander Verheule
P2860
P356
10.1093/EURHEARTJ/EHW119
P577
2016-04-12T00:00:00Z